Am J Transplant, Volume 19, Suppl 3 Archives - Page 91 of 214 - ATC Abstracts

2019 American Transplant Congress
The Feasibility Of Donation After Cardiac Death In Liver Transplantation: A Registry Analysis
A. C. Gruessner, R. Misawa, A. Masi, Z. Moghadamyeghaneh, J. F. Renz, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Utilization of liver allografts from donation after cardiac death (DCD) has gradually increased in the United States. We aimed to analyze overall utilization of…
2019 American Transplant Congress
Intraoperative Blood Loss and Transfusion during Pediatric Liver Transplantation: A Single Center Experience
J. A. Villarreal¹, D. Yoeli², J. Yoeli³, R. Ackah⁴, R. Sigireddi¹, M. Kueht¹, N. Galvan¹, R. Cotton¹, A. Rana¹, C. O’Mahony¹, J. Goss¹
¹Surgery, Baylor College of Medicine, Houston, TX, ²Surgery, University of Colorado School of Medicine, Denver, CO, ³Pediatrics, University of Colorado School of Medicine, Denver, CO, ⁴Surgery, The Ohio State University College of Medicine, Columbus, OH
*Purpose: The aim of this study is to identify risk factors for massive intraoperative blood loss and transfusion in pediatric liver transplant recipients and describe…
2019 American Transplant Congress
Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension
C. Ju, Q. Lian, B. Wei, X. Xu, J. He, R. Chen
State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China
*Purpose: Heart-lung transplants (HLTx) is the only one effective strategy for advanced pulmonary arterial hypertension (PAH) with refractory right heart failure. But limited availability of…
2019 American Transplant Congress
Synergistic Effect of HLA Eplet Mismatch Load and CMV Viremia on Clinical Antibody-Mediated Rejection in Lung Transplantation
Y. Im¹, S. Yeramaneni², Y. Yim³, J. Dodderer⁴, M. Askar¹, H. J. Huang⁵
¹Baylor University Medical Center, Dallas, TX, ²Baylor Scott & White Health, Dallas, TX, ³Ross University School of Medicine, Portsmouth, Dominica, ⁴Texas Tech University Health Sciences Center, El Paso, TX, ⁵Houston Methodist Hospital, Houston, TX
*Purpose: De novo donor specific antibodies (dnDSA) occur in up to 50% of lung transplant (LUTX) recipients within one year and are associated with increased…
2019 American Transplant Congress
Severe Hyponatremia with Intraoperative Desmopressin Use in (Deceased and Living Donor) Renal Transplant Recipients
M. Gill, S. Kuppachi, C. Thomas
Division of Nephrology, University of Iowa Hospital and Clinics, Iowa City, IA
*Purpose: Desmopressin (DDAVP) is used for hemostasis in patients with factor VIII deficiency, von Willebrand disease and platelet function defects including that seen in patients…
2019 American Transplant Congress
Evaluation Of Workplace Environment In Transplant Medicine: Harassment Should Not Be The “Reality Of Life”
M. Reilly¹, T. Branstool¹, S. Gregory¹, T. R. Pearson², T. S. Purnell³, G. Gunasekaran⁴, B. Kelly⁵, P. N. Martins⁶, C. M. Mobley⁷, S. M. Black⁸, E. C. Maynard⁹, D. C. Simpson¹⁰, M. B. Shah¹¹, O. Ekwenna¹, J. Locke¹², J. Ortiz¹
¹Surgical Transplant, University of Toledo College of Medicine and Life Sciences, Toledo, OH, ²Froedtert and the Medical College of Wisconsin, Milwaukee, WI, ³Johns Hopkins School of Medicine, Baltimore, MD, ⁴Mount Sinai Medical Center, New York, NY, ⁵DCI Donor Services, Nashville, TN, ⁶University of Massachusetts, Amherst, MA, ⁷Houston Methodist, Houston, TX, ⁸The Ohio State University, Columbus, OH, ⁹Oregon Health and Science University, Portland, OR, ¹⁰Northwestern University, Evanston, IL, ¹¹University of Kentucky, Lexington, KY, ¹²University of Alabama at Birmingham, Birmingham, AL
*Purpose: The recent increase in publications detailing discrimination and harassment in the medical setting has brought to light potential impairments of medical professional health and…
2019 American Transplant Congress
Build It, They Will Come: Surgical Renal Outpatient Infusion Room Decreases Readmission Rates
J. Truckenbrod¹, K. DeWall¹, M. Jones¹, E. VanLith¹, M. Anderson¹, L. Jaeger¹, M. Phillips², W. Kendall¹, L. Burris¹, T. Thambi¹
¹Transplant, Sanford USD Medical Center and Hospital, Sioux Falls, SD, ²Surgical Renal, Sanford USD Medical Center and Hospital, Sioux Falls, SD
*Purpose: Post-renal transplant patients present a unique set of complex medical concerns that are best served by qualified, transplant-trained healthcare professionals. Post-renal transplant patients often…
2019 American Transplant Congress
Ex-vivo Xenoperfusion Of Wild Type And Galtko.hcd55 Pig Livers With Human Whole Blood
D. Detelich, C. Rickert, C. Eymard, C. Carroll, S. Kimura, H. Yeh, J. Markmann
Massachusetts General Hospital, Boston, MA
*Purpose: Pig-to-human liver xenotransplantation is not currently feasible due to rapid and profound thrombocytopenia, coagulopathy and hyperacute rejection. Successful development of genetically modified swine to…
2019 American Transplant Congress
Evaluation Of Complement-related Factors In Tma Post-kidney Transplantation: A Retrospective Multicenter Study
N. Fujiyama¹, M. Tasaki², H. Harada³, K. Tsutahara⁴, A. Matsumoto⁵, Y. Hara⁶, M. Okumi⁷, K. Saito², Y. Watarai⁸, N. Inoue⁹, N. Wakamiya⁹, S. Satoh¹
¹Center for Kidney Disease and Transplantaion, Akita University Hospital, Akita, Japan, ²Department of Urology, Niigata University, Niigata, Japan, ³Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan, ⁴Department of Urology, Osaka General Medical Center, Osaka, Japan, ⁵Department of Urology, The University of Tokyo, Tokyo, Japan, ⁶Department of Nephrolog, Shinsyu University Hospital, Shinsyu, Japan, ⁷Department of Urology, Tokyo Women’s Medical University, Tokyo, Japan, ⁸Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan, ⁹The Japanese Association for Complement Research, Osaka, Japan
*Purpose: Post-kidney transplant thrombotic microangiopathy (KT-TMA) is a poor prognostic complication that causes a high rate of graft loss. In this study, we investigated KT-TMA-associated…
2019 American Transplant Congress
Outcome Of Living Donor Liver Transplantation In Elderly Patients >65 Years With And Without Hepatocellular Carcinomas: A Retroepsective Analysis
A. Thorat, L. Jeng, S. Hsu, H. Yang, C. Yeh, T. Chen, K. Poon, P. Li
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan
*Purpose: The elderly patients > 65 years with end-stage liver disease that require liver transplantation has been steadily increased over last decade in Taiwan and…